Xeljanz

Xeljanz (tofacitinib) is an oral medication used for inflammatory conditions. It belongs to the JAK inhibitor class and is prescribed when other treatments are insufficient. This overview covers its uses, effects, and safety considerations for general understanding. Always consult a healthcare professional before use.

Xeljanz is primarily used to manage moderate to severe rheumatoid arthritis in adults. It may also be prescribed for psoriatic arthritis or ulcerative colitis when conventional therapies are ineffective. This medication works by targeting specific pathways in the immune system to reduce inflammation and joint damage. Patients often ask, 'what is Xeljanz used for' to understand its role in treatment plans.

Many users report reduced joint pain and swelling after starting Xeljanz, though individual responses vary. Some experience improved mobility and daily functioning over time. Common effects may include mild nausea or headaches, especially when first taking the medication. These effects are generally temporary and should be discussed with a healthcare provider if persistent.

Xeljanz should be stored in a cool, dry place away from direct sunlight. Keep it out of reach of children and pets to prevent accidental ingestion. Patients with a history of infections or certain cancers should use this medication with caution. Regular monitoring by a healthcare professional is recommended during treatment.

Xeljanz may interact with other immunosuppressants, increasing infection risk. Combining it with strong CYP3A4 inhibitors (e.g., ketoconazole) can raise drug levels in the blood. Alcohol use may exacerbate side effects like dizziness or liver stress. Always inform your doctor about all medications and supplements you take.